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ABSTRACT
CAPNS1 is essential for the stability and function of ubiquitous CAPN1 and CAPN2. Calpain modulates by
proteolytic cleavage many cellular substrates and its activity is often deregulated in cancer cells, therefore
calpain inhibition has been proposed as a therapeutical strategy for a number of malignancies. Here we
show that CAPNS1 depletion is coupled to impairment of MCF7 and MCF10AT cell lines growth on plate
and defective architecture of mammary acini derived from MCF10A cells. In soft agar CAPNS1 depletion
leads to cell growth increase in MCF7, and decrease in MCF10AT cells. In both MCF7 and MCF10AT,
CAPNS1 depletion leads to the enlargement of the stem cell compartment, as demonstrated by
mammosphere formation assays and evaluation of stem cell markers by means of FACS and western blot
analysis. Accordingly, activation of calpain by thapsigargin treatment leads to a decrease in the stem cell
reservoir. The expansion of the cancer stem cell population in CAPNS1 depleted cells is coupled to a
defective shift from symmetric to asymmetric division during mammosphere growth coupled to a
decrease in NUMB protein level.
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Introduction
CAPNS1 regulatory subunit is essential for the stability and
function of ubiquitous calpain-1, CAPN1 and calpain-2,
CAPN2.14 Both CAPN1 and CAPN2 are generally overex-
pressed upon transformation.15 CAPN1 expression is associ-
ated with relapse-free survival in breast tumors from patients
treated with trastuzumab following adjuvant chemotherapy.16
Conversely, high expression of CAPN2 in basal-like or triple-
negative disease was associated with adverse breast cancer-spe-
ciﬁc survival.17 We reported that CAPNS1 interferes with
PP2A-Akt interaction, consequently affecting FoxO3A-depen-
dent cell death in mouse embryonic ﬁbroblasts and human
MCF7 cells. We therefore suggested that ubiquitous Calpain
inhibition might be exploited as a tool to induce apoptosis in
tumors sensitive to FoxO activation.1 In accordance with our
ﬁndings, CAPN2 regulates proliferation, survival, migration,
and tumorigenesis of breast cancer cells in mouse models, via
the PP2A-Akt-FoxO-p27Kip1 signaling axis.6 CAPN1 stabilizes
USP1 deubiquitinating enzyme during the G1 phase of the cell
cycle in human osteosarcoma cells and ﬁbroblasts, indeed cal-
pain inhibits USP1 proteasomal degradation, acting as a break
on the CDK5/APC/Ccdh1 axis.2 USP1 belongs to the class of
Fanconi anemia proteins that are required for DNA repair of
interstrand crosslinks and consequently for genome stability
maintenance. FANCD1/BRCA2, another essential protein of
the Fanconi anemia repair pathway, also plays a key role in the
BRCA repair pathway, a safeguard against breast cancer, sug-
gesting the existence of functional overlapping between the 2
machineries. USP1 stabilizes the inhibitor of differentiation
ID2 and consequently preserves cellular stemness in undiffer-
entiated osteosarcomas19 therefore represents suitable targets
for differentiation therapy of speciﬁc tumors.3 Notably, a recent
study reported that the expression of the USP1 target ID2 was
directly associated with the Nottingham Prognostic Index,
worsening clinical outcome and with worse disease-free and
overall survival in human breast cancer.18 In this study we
unveiled a multifacet effect of CAPNS1 depletion in breast can-
cer biology, including a destabilizing effect of NUMB protein, a
well known protein switch from symmetric to asymmetric cel-
lular division.13,10,8,12
Results
CAPNS1 depletion in MCF7 and MCF10AT cells perturbs
both anchorage dependent and independent growth
In order to investigate the effect of CAPNS1 depletion on
anchorage dependent and independent growth of breast cancer
cells, colony assays and soft agar assays were performed using
both luminal type MCF7 and basal like MCF10AT cell line.
CAPNS1 depleted MCF7 and MCF10AT cells and respective
wild type controls were seeded on tissue culture plates and 2
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weeks later the number of colonies was counted after staining
with crystal violet. As it is shown in the representative pictures
and in the graphs of Figure 1A and B, CAPNS1 depletion is
coupled to a reduction of cellular growth on tissue culture
plates. The effect of calpain on anchorage dependent growth of
breast cancer cells conﬁrms a previous study that demonstrated
an essential role for this protease in cell adhesion mediated by
paxillin cleavage.4
Next, CAPNS1 depleted MCF7 and MCF10AT cells and
respective controls were employed for soft agar assays accord-
ing to standard procedures. Three weeks after cells seeding,
pictures were taken and analyzed by Image J software. Typical
Figure 1. CAPNS1 depletion alters breast cancer cells growth on plate and in soft agar. Control and CAPNS1 depleted MCF7 cells (1A) or MCF10AT (1B) were plated on
6 cm dishes at the indicated concentration. Two weeks later, the cells were stained with crystal violet and images were acquired by Epson scanner. Images of representa-
tive experiments are shown. Colonies were counted using image J software; the graph reports the average of 3 independent experiments (p values <0.01). Control and
CAPNS1 depleted MCF7 cells (1C) or MCF10AT (1D) were resuspended in 0.3 % agar and the indicated number of cells was plated on 1% agar according to standard pro-
cedures. Three weeks later colonies were counted. The graphs report the average number of colonies counted in 3 independent experiments (p values <0.01). Represen-
tative pictures are shown next to the graphs.
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colonies are shown in Figure 1C, 1D, and the average number
of colonies counted in 3 independent experiments are indicated
in the graphs. CAPNS1 depletion enhances the growth of
MCF7 in soft agar, while its loss impairs the growth of
MCF10AT cells in the same semisolid medium. A similar out-
come of CAPNS1 depletion on cell growth both on plates and
in soft agar was reported for the highly metastatic AC2M2
mouse mammary cells.6 It is not surprising that interfering
with essential enzymes like calpain may produce opposite
effects not only in different genetic settings, but also in alterna-
tive growing environments.
Calpain modulates mammary acini formation
To assess whether calpain may play a role in the maturation of
mammary acini, we performed 3D studies using MCF-10A
cells, a widely used model system for understanding epithelial
cell biology. When plated in a mixture of collagen and laminin
MCF10A cells form 3D structures that resemble acini struc-
tures of the human breast. The size of the acini is sharply
reduced in CAPNS1 depleted cells as compared to control ones
(Fig. 2A, C), although the number of acini is not affected
(Fig. 2B). Staining with GM130, b-catenin and E-cadherin spe-
ciﬁc antibodies (Fig. 2D) revealed that the architecture of acini
derived from CAPNS1 depleted cells is perturbed. These data
suggest that calpain is required for the correct formation of the
basic unit of breast epithelium and may play an important role
in the initiation of the differentiation process in this system.
The same type of analysis was performed in MCF10AT cells,
the Rasv12 transformed derivative of MCF10A cells. In this sys-
tem the differences between control and CAPNS1 depleted cells
appear less evident, since also control cells have lost the capac-
ity to form acini with well deﬁned cavities, as already reported
by others (Supplementary 1A, 1B).
To address the role of CAPNS1 in stem cell maintenance
and differentiation in a more general context, we employed
mice embryonic stem (ES) cells. CAPNS1 was knocked out by
siRNA in mice ES cells prior the induction of differentiation
and the kinetics of disappearance of stem cell markers was
investigated by real time PCR. CAPNS1 depletion does not
alter the kinetics of disappearance of stem cell markers, indicat-
ing that its depletion is not sufﬁcient to affect differentiation in
this system. However, CAPNS1 mRNA levels clearly decrease
upon differentiation, just as the standard stem cell markers,
OCT4 and SOX2 and NANOG (Fig. 2E). A similar behavior is
observed for USP1 that is involved in a calpain-modulated axis
in osteosarcoma and MEFs.2
Calpain modulates breast cancer stem cells compartment
Cancer stem cells are considered the fuel of cancer recurrence
and therefore, a satisfactory chemotherapy must be effective
also against this cancer reservoir. The assay of choice to assess
the role of speciﬁc genes/pathways in stem cell maintenance/
growth in vitro is the mammospheres formation assay. We ﬁrst
applied this methodology to MCF7 cells where CAPNS1 deple-
tion is linked to a decrease of growth in 2D, but an increase of
growth in soft agar. In this system CAPNS1 depletion is linked
to an increase in mammosphere formation efﬁciency (Fig. 3B),
and to an alteration of mammospheres shape that is less spheric
respect to control (Fig. 3A).
Next, we applied mammosphere assay to MCF10AT cells
where calpain depletion is coupled to a decrease of both
anchorage dependent and independent growth. The shape of
Figure 2. CAPNS1 depletion does not affect mammary acini number, but is
involved in mammary acini growth and architecture. (A) Representative bright ﬁeld
pictures of control (left panel) and shCAPNS1 (right panel) MCF10A cells grown in
3D. Scale bar corresponds to 50 mm. (B) Average number of acini counted in 3
independent experiments (p value D 0.2). (C) Percentage of acini of different
dimensions as indicated. The graph represent mean values obtained in 3 indepen-
dent experiments (p values <0.01). (D) Representative immunoﬂuorescence pic-
tures of control (upper panels) and shCAPNS1 (lower panels) MCF10A cells grown
in 3D, stained with the indicated antibodies. Scale bar corresponds to 50 mm.
(E) Mouse embryonic stem cells were silenced with control siRNA or CAPNS1
speciﬁc siRNA and grown in differentiation media. The graph indicates the quanti-
ﬁcation of mRNA expression of the indicated transcripts by real time PCR analysis
(p values <0.01).
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mammospheres derived from CAPNS1 depleted cells is more
irregular as compared to the shape of control mammospheres,
as it is the case for MCF7 cells (Fig. 3C). Also in this system,
CAPNS1 depletion is coupled to an increase in mammospheres
formation efﬁciency (Fig. 3D). On the basis of these ﬁndings
we hypothesized that calpain activation could hamper the
expansion of the stem cell population. To verify this hypothesis,
100 nM thapsigargin was added for 6 hours to the ﬁrst genera-
tion mammospheres to induce calcium release from the endo-
plasmic reticulum and activate calpain. Such treatment does
not signiﬁcantly affect cell viability, as monitored by a cell via-
bility assay and FACS analysis performed 48 hours after treat-
ment (Data not shown). Control and CAPNS1 depleted
MCF10AT cells were employed for a standard mammosphere
formation assay. After counting the mammospheres of the ﬁrst
generation M1, the cells were either treated or not with 100 nM
thapsigargin to activate calpain. Six hours later, the mammo-
spheres number was counted again before harvesting and dis-
aggregation. Afterwards, equal amounts of cells were seeded in
mammosphere speciﬁc medium. The number of mammo-
spheres in the subsequent generation, M2, decreases in thapsi-
gargin treated cells, and the entity of the reduction in control
cells is almost twice the reduction occurring in CAPNS1
depleted cells (Fig. 3E). Notably, calpain activation by ionomy-
cin has the same effect of thapsigargin on mammosphere form-
ing efﬁciency, and the calcium chelator BAPTA prevents such
Figure 3. Calpain affects mammosphere forming efﬁciency. Control and CAPNS1 depleted MCF7 and MCF10AT cells were plated in 96 wells multiwell plates (1000 cells/
well) in mammosphere speciﬁc medium. After ten days, the mammospheres were collected and disaggregated. Mammospheres derived cells were counted and plated
as for the ﬁrst generation and 7 d later picture were taken. (A) typical MCF7 mammospheres. Scale bar corresponds to 50 mm. (B) reports the average number of second
generation MCF7 mammospheres obtained in 3 independent experiments (p values <0.01). (C) typical MCF10AT mammospheres. Scale bar corresponds to 50 mm.
(D) reports the average number of second generation MCF10AT mammospheres obtained in 3 independent experiments (p values <0.01). (E) shows the average
number of mammospheres counted in 3 independent experiments in control and shCAPNS1 MCF10AT treated or not treated with thapsigargin
(p values<005). Brieﬂy, control and CAPNS1 depleted MCF10AT cells were plated on 96 wells multiwells (1000 cells/well) in mammosphere speciﬁc medium. After
7 days, the mammospheres were incubated or not with 100 nM thapsigargin for 6 hours. Mammospheres derived cells were counted and plated as for the ﬁrst generation
and 7 d later the number of second generation mammospheres was counted. Control and CAPNS1 depleted MCF10AT cells derived from second generation mammo-
spheres were stained with anti CD44 and anti CD24 antibodies and analyzed by FACS. Adherent cells were analyzed in parallel. The dot plot (F) and the graph
(G) are the results of a typical FACS analysis.
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effect (data not shown). These results show that transient cal-
pain activation may limit stem cell expansion.
In order to further verify the increase of stem cell population
in CAPNS1 depleted cells, parental adherent cells and mammo-
spheres derived cells were collected and analyzed by FACS to
evaluate the surface expression of the widely recognized stam-
inality markers CD44 and CD24. Cells derived from mammo-
spheres originated from CAPNS1 depleted cells are clearly
more enriched in the CD24 low/CD44 high population as com-
pared to control cells (Fig. 3F, G).
CAPNS1, a novel marker of breast cancer stem cells and
mouse embryonic stem cells
CAPNS1 depleted MCF10AT cells and respective controls were
sorted by FACS in order to isolate the CD44 high/CD24 low
population from each cell line. An aliquot of sorted cells was
utilized for nuclear/cytoplasmic fractionation and western blot
analysis, and the remaining cells were employed for mammo-
sphere formation assays. As expected, E-cadherin protein level
is lower in sorted cells as shown in Figure 4A, indicating that
epithelial-mesenchymal transition is taking place in CD44
high/CD24 low MCF10AT cells. Notably, as already observed
for osteosarcomas and MEFs, full length USP1 (indicated by an
arrow) decreases in CAPNS1 depleted cells. Interestingly, both
calpain and USP1 are more abundant in the sorted CD44 high/
CD24 low cell population, enriched in cancer stem cells. In par-
ticular, CAPN1 is present also in the nuclear compartment and
USP1 is present also in the cytoplasmic compartment in the
cancer stem cells enriched population. Our ﬁndings suggest
that calpain and USP1 may be novel markers of breast cancer
stem cells.
As already observed for unsorted cells, the CD44 high/
CD24 low population derived from CAPNS1 depleted cells
is characterized by an increase in ﬁrst generation mammo-
sphere forming efﬁciency (Fig. 4B). This result is in accor-
dance with the higher surface expression of CD44 in
CAPNS1 depleted sorted cells, shown in Figure 3F, G. The
number of second generation mammospheres originated
from CD44 high/CD24 low MCF10AT cells is unaffected by
CAPNS1 depletion possibly due to exhaustion of stem cell
potential. Indeed, the size of mammospheres originated
from CAPNS1 depleted cells, is signiﬁcantly larger, as quan-
tiﬁed and reported in Figure 4C.
Calpain acts as a switch from symmetric
to asymmetric division
On the basis of the data reported above, we hypothesized
that calpain may be involved in the switch from symmetric
division to asymmetric division at the onset of differentia-
tion of human mammary cells. In order to investigate
whether calpain is involved in this switch, we followed the
distribution of the vital dye PKH26 during the growth of
mammosphere originated from control cells and from
CAPNS1 depleted cells. Two representative pictures are
shown in Figure 4D and the quantiﬁcation of the percent-
age of the surface of the mammospheres that retains
PKH26 is shown in graph 4E. Notably, the surface of
stained mammospheres, that reﬂects the number of stained
cells, is larger when CAPNS1 is depleted.
As a ﬁrst approach to understand the molecular basis of
the expansion in cancer stem cells coupled to CAPNS1
depletion, the levels of key proteins in cell extracts from
adherent cells and mammospheres of the ﬁrst and second
generation were evaluated by western blot. As it is shown
in Figure 4F, comparing adherent cells to mammospheres,
E-cadherin protein levels decrease, while vimentin becomes
more abundant both in control and CAPNS1 depleted cells,
as expected when epithelial/mesenchimal transition is taking
place. Notably, active beta-catenin, that positively modulates
mammary stem cells long-term expansion, is more abun-
dant in CAPNS1 depleted adherent and M1 cells as com-
pared to the control counterparts, in accordance with the
increase in cancer stem cells characteristics reported above
for CAPNS1 depleted cells. Genotoxic stress was shown to
activate p21 and consequently to induce symmetric division
in mammary cancer stem cells, leading to the expansion of
stem cell compartment.7 Interestingly, p21 is more abun-
dant in mammospheres from CAPNS1 depleted cells, as
compared to control cells, further supporting the expansion
of the stem cell compartment in CAPNS1 depleted
mammospheres.
CAPNS1 reintroduction rescues the wild type phenotype
and reduces stem cells expansion
To verify whether CAPNS1 reintroduction could rescue the
phenotype observed in CAPNS1 depleted mammospheres, we
produced a novel set of MCF10AT cell lines: a control cell line,
a CAPNS1 depleted cell line and a CAPNS1 depleted cell line,
expressing a CAPNS1 mRNA resistant to CAPNS1 silencing
(Fig. 5A). Mammosphere formation assay was performed, con-
ﬁrming an increase in mammosphere formation efﬁciency in
CAPNS1 depleted cells. Notably, CAPNS1 reintroduction is
coupled to a reduction of mammosphere forming efﬁciency,
further conﬁrming that the expansion of the stem cell compart-
ment observed in CAPNS1 depleted cells is dependent on
CAPNS1 (Fig. 5B).
The three cell lines were further employed for mammo-
sphere formation and staining with PKH26. Pictures were
taken at subsequent time points, namely 3, 5, 7, 10 d after stain-
ing and seeding. Typical pictures are shown in Figure 5D. In
order to quantify the number of PKH26 positive cells, FACS
analysis was performed 9 days after staining (Fig. 5C). These
novel sets of experiments further conﬁrm that the number of
cells retaining the PKH26 die negatively correlates with
CAPNS1 protein level.
NUMB protein level is lower in CAPNS1 depleted cells
Numb is an essential modulator of the shift between sym-
metric and asymmetric division, therefore we evaluated
NUMB protein level in CAPNS1 depleted MCF7, MCF10A
and MCF10AT cells, as compared to control cells. NUMB
level is lower in CAPNS1 depleted MCF7 cells, while it is
apparently unaffected by CAPNS1 depletion in MCF10A
and MCF10AT cells (Fig. 6A). However, analysis of nuclear
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and cytoplasmic fractions of MCF10AT cells shows that
NUMB protein level is lower in cytoplasms extracted from
CAPNS1 depleted as compared to control ones (Fig. 6B).
The decrease in NUMB protein level coupled to CAPNS1
depletion is sharper in the cytoplasms of CD44 high/CD24
low population (Fig. 6C).
Why the increase in the expansion of the stem cell com-
partment is sharper in MCF7 cells than in MCF10AT cells?
We previously reported that CAPNS1 positively modulates
USP1 stability in osteosarcoma and MEFs. Since USP1 inhi-
bition/depletion was shown to induce differentiation in vari-
ous cellular contexts, we hypothesized that USP1 reduction
might buffer the effect due to NUMB reduction.
CAPNS1 was transiently depleted in MCF10A, MCF10AT,
MCF10CA1, MCF7 cells and USP1 level was evaluated by west-
ern blot. As expected, USP1 level decreases in MCF10A and
MCF10AT cells, upon CAPNS1 depletion, but it is unaffected
in MCF7 cells.
Figure 4. CAPNS1 depletion is coupled to breast cancer stem cells expansion.CD44C/CD24- population was sorted by FACS analysis from CAPNS1 depleted and control
MCF10AT cells. Nuclear and cytoplasmic extracts obtained from sorted cells and analyzed by western blot with the indicated antibodies (A). In parallel, sorted CD44C/
CD24- cells were utilized for mammosphere formation assay. (B) reports the average mammosphere forming efﬁciency for the ﬁrst (M1) and second generation (M2) (p
values <005). (C) reports the average MFE of second generation mammospheres with diameter larger than 250 micrometres (p values <005). (D, E) Control and
shCAPNS1 MCF10AT were stained with PHK26 vital dye and after extensive washing were plated in mammosphere forming medium. Pictures were taken after 2 weeks.
Scale bar corresponds to 50 mm. The percentage of PKH26 stained area of 4 planes of 4 control and 4 shCAPNS1 mammospheres was measured by Image J and is
reported in the graph. (F) CAPNS1 depleted and control adherent MCF10AT cells and cells derived from ﬁrst and second generation mammospheres derived from the
same cells were lysed and analyzed by western blot with the indicated antibodies.
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Discussion
CAPNS1 depletion is coupled to a reduction of growth on
plates in both epithelial MCF7 and basal like MCF10AT cancer
cells. On the other hand, CAPNS1 depletion has opposite
effects on soft agar growth of MCF10AT and MCF7 and
suggest that when cancer cells bypass the ﬁrst environmental
barrier and become able to grow in an anchorage independent
manner, the overall role of calpain may vary in different genetic
settings. The positive effect of CAPNS1 on MCF10AT cells
growth in soft agar is in accordance with the previously
reported negative role of APC/Ccdh1 in the same experimental
Figure 5. CAPNS1 depletion is linked to expansion of PKH26 stained cells that can be rescued upon CAPNS1 reintroduction. (A) CAPNS1 expression in MCF10AT cell lines:
control MCF10AT, shCAPNS1 MCF10AT, shCAPNS1 MCF10AT stably expressing siRNA resistant CAPNS1. (B) Average number of mammosphere number obtained in 3 inde-
pendent experiments with MCF10AT derived cell lines described above (p values<005). (C) Average of PKH26 stained cells in mammospheres obtained in 3 independent
experiments (p values <005). (D) Subsequent pictures taken 3, 5, 7, 9 d after seeding of representative mammosphere obtained from the above described cell lines. Scale
bar corresponds to 50 mm.
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system.5 Indeed, calpain negatively modulates APC/Ccdh12,11
and therefore in CAPNS1 depleted cells, APC/Ccdh1 is more
active and growth results impaired.
The negative effect of CAPNS1 depletion on the growth
of MCF10AT cells demonstrated by colony and soft agar
assays is in accordance with the results obtained by Wai
Chi-Ho et al. in ACM2 cells.6 Interestingly, they demon-
strate that while CAPN2 knockout reduced tumor growth in
a breast tumor engraftment model, lung metastasis was not
affected by CAPN2 depletion and the percentage of mice
with metastasis in the 2 reported experiments was higher
when CAPN2 depleted cells were injected. This result is in
agreement with our ﬁnding on the expanded cancer stem
cell compartment in CAPNS1 depleted MCF7 and
MCF10AT cells. Accordingly, we have shown that calpain
activation reduces the expansion of this compartment in a
calpain dependent manner. Cancer stem cells are resistant
to standard therapies that reduce the bulk of the tumor.
Thus new therapies speciﬁcally targeting this tumor reser-
voir are warranted.
Altogether previously published data and our ﬁndings
highlight a role of calpain as a master director of cellular
architecture and cell fate decision. In this study we have also
demonstrated by mammosphere formation assays, western
blot and FACS analysis of breast cancer stem cell markers
that calpain depletion increases the ampliﬁcation of the
breast cancer stem cell compartment. The vital dye PKH26
used to stain the individual cancer stem cells is inherited by
a larger number of daughter cells when CAPNS1 is depleted,
indicating a longer persistence of symmetric division.
Accordingly, NUMB protein, a master regulator of the shift
between symmetric to asymmetric division that is coupled to
differentiation, is reduced in CAPNS1 depleted cells.
Materials and methods
Chemicals and reagents
Thapsigargin and PKH26 were bought from Sigma-Aldrich.
LipofectamineTM RNAiMAX from Invitrogen. USP1 speciﬁc
siRNA with the following sequence: AACCCUAUGUAU-
GAAGGAUAU was purchased from Euroﬁns Mwg/Operon.
RNAi oligonucleotides speciﬁc for CAPN1, Cdk5 and cdh1
were purchased from Santa Cruz Biotechnology. CAPN2 RNAi
and SMARTpool for CAPNS1 silencing were purchased from
DHARMACON, Inc., Dallas, TX (USA). AllStars Negative
Control siRNA (Qiagen) was used as negative control.
Cell culture and transfections
MCF-7 cells were grown in Eagle’ s Minimum Essential
Medium supplemented with 10% fetal calf serum, 1% Penicil-
lin/Streptomycin (Lonza) and Non essential Amino Acid
Solution 100X (Sigma). MCF10A and MCF10AT cells were cul-
tured in DMEM:F12 media (1:1) supplemented with 10mg/ml
Insulin (Sigma), 20ng/ml EGF (PEPROTECH), 500ng/ml
hydrocortisone (Sigma), 5% horse serum, 10U/ml Penicillin,
100mg/ml Streptomycin and 1% HEPES (Gibco). MCF10CA1
were cultured in DMEM:F12 media (1:1) supplemented with
10% foetal calf serum, 1% Penicillin/Streptomycin (Lonza).
MDA-MB231 and MDA-MB468 were grown in Dulbecco’s
modiﬁed Eagle’s Medium (DMEM) supplemented with 10%
foetal calf serum, 1% Penicillin/Streptomycin (Lonza). SKBR3
cells were grown in RPMI supplemented with 10% foetal calf
serum, 1% Penicillin/Streptomycin (Lonza). Mouse embryonic
stem (ES) cells were cultured on 0.2% gelatin-coated plates in
mESC self-renewal medium: Dulbecco’s modiﬁed Eagle’s
Figure 6. CAPNS1 depletion is coupled to a decrease in NUMB protein level.NUMB protein level was compared by western blot in CAPNS1 depleted versus control cells,
using total cell lysates of MCF7, MCF10A and MCF10AT cells (A) nuclear and cytoplasmic extracts of MCF10AT cells (B) and cytoplasms from CD44 high/CD24 low sorted
MCF10AT cells (C). (D) CAPNS1 speciﬁc, USP1 speciﬁc or a control siRNA were transfected in the indicated cell lines. 48 hours later, lysates were analyzed by western blot
to monitor USP1 and CAPNS1 levels. Actin was used as loading control.
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medium (DMEM) supplemented with 15% knockout serum
replacement (Gibco), 1% nonessential amino acids (Gibco),
1 mM sodium pyruvate (Invitrogen), 0.1 mM ß-mercaptoetha-
nol, 1% penicillin/streptomycin (Invitrogen), and 1,000 U/ml
mouse leukemia inhibitory factor (LIF). All cells were grown in
5% CO2 at 37C in a humidiﬁed incubator. MCF10A,
MCF10AT, MCF10CA1 (obtained from Karmanos Cancer
Institute, US), MCF-7, MDA-MB-231, MDA-MB468 and
SKBR3 cells at 60–80% conﬂuence, and ES cells at low conﬂu-
ence were transiently oligofected using Lipofectamine RNAi-
MAX (Invitrogen) according to the manufacturer’s
instructions.
Viral constructs
shCAPNS1 was obtained by annealing the following sense oli-
gonucleotide: 50- GAT CCC CGC CAC AGA ACT CAT GAA
CAT TCA AGA GAT GTT CAT GAG TTC TGT GGC TTT
TTA - 30 to the following antisense oligonucleotide: 50 - AGC
TTA AAA AGC CAC AGA ACT CAT GAA CAT CTC TTG
AAT GTT CAT GAG TTC TGT GGC GGG G - 30. The
annealed product was inserted by standard procedures in pRe-
troSuper vector, previously linearized by BglII and HindIII
digestion, and checked by sequencing.
Cell infections
293GP packaging cells were transfected with the calcium-phos-
phate method with pRetroSuper-shCAPNS1 or vector alone,
after 72 hours the supernatant was harvested, ﬁltered and
added to MCF10AT or MCF-7 cells. The infected cells were
selected by the addition of puromycin and after 7 d the expres-
sion of CAPNS1 was checked by western blot.
Colony formation assay
Cells were seeded at 1000 cells/ml and 2000 cells/ml for MCF-7
and 100 cells/ml and 300 cells/ml for MCF10AT in a 21 cm2 cell
culture dish and incubate at 37C in a humidiﬁed, 5% CO2 atmo-
sphere. After incubation for 15 days, cell culture plates containing
colonies were gently washed with PBS twice, ﬁxed with 4% para-
formaldehyde for 20 minutes at room temperature and stained
with 0.5% Crystal violet. Excess stain was removed by washing
repeatedly with PBS and colonies were counted. For quantiﬁca-
tion, the colonies were analyzed using ImageJ software. Three
reduplicate dishes were used from each condition.
Soft-agar assay
To evaluate anchorage-independent growth, 5 £ 103 and 1 £
104 MCF-7 cells and MCF10AT were resuspended in 0.3% aga-
rose in growth media. Cells were plated on a solidiﬁed bed of
1% agarose in growth media in 21 cm2 plates. Plates were incu-
bated for 3 weeks at 37C. Bright ﬁeld images of MCF-7 and
MCF10AT colonies were taken using a 10£ objective. The
number of colonies per ﬁeld was counted using ImageJ soft-
ware. The experiments were conducted in triplicate.
Three dimensional culture
3D culture was carried out based on the method as already
described by others.9 Brieﬂy, 12 mm round glass coverslips were
coated with 80 ml of ice-cold rBM (Cultrex) and incubated at
37C for 20 minutes to allow rBM to solidify. The coated cover-
slips were placed in a 24-well plate with the rBM facing up. Single
cell suspensions containing 7000 cells/well for MCF10A and 5000
cells/well for MCF10AT, were resuspended in 250ml of complete
growth medium with 2% (v/v) of Cultrex and plated on top of the
rBM coated chamber slides and incubated at 37C for 30 minutes
to let the cells attach. Then 250ml of the assay medium was added
per well and the cells were cultured al 37C and 5% CO2 for 3
weeks, with the medium being changed every 3 d.
Immunostaining and microscopy
The three-dimensional structures in rMB Cultrex were ﬁxed in
4% paraformaldehyde at room temperature for 20 minutes,
permeabilized with 1% Triton X-100 in PBS for 15 minutes and
washed with 100 mM glycine in PBS, 3 times at 10 min/wash.
After the 3-dimensional structures were blocked with IF
(immunoﬂuorescent) blocking buffer (0.1% BSA, 0.2% Triton
X-100, 0.05% Tween 20, 7.7 mM NaN3, in PBS) containing
10% normal goat serum for 1h and incubated overnight at 4C
with the following primary antibodies: anti-GM130 (BD Bio-
sciences), anti-E-cadherin (Takara bio) and anti-bcatenin
(Santa Cruz). Samples were then washed with IF buffer (0.1%
BSA, 0.2% Triton X-100, 0.05% Tween 20, 7.7 mM NaN3, in
PBS) 3 times at 20 min/wash and stained with secondary anti-
body for 1h at room temperature. This was followed by 3
washes with IF buffer at 10 min each. To stain the nuclei, the
slides were incubated with RNase 200mg/ml for 15 min at
room temperature and then stained with Propidium Iodide
25mg/ml for 5 min at room temperature, washed 3 times with
PBS and mounted on glass coverslips. Confocal microscopic
images of the acinus structures were captured by the Z-stacking
function for serial confocal sectioning (LSM-510 META confo-
cal microscope) and then analyzed by ImageJ software. The
experiments were conducted in triplicate.
Mammosphere cultures
To generate mammospheres, conﬂuent monolayers cells were
trypsinized, counted and plated as single suspension (1000
cells/well) in a low attachment plates (Corning) and grown in
non-adherent culture conditions, as described in Dontu et al,
2003. MCF10AT cells were grown in a serum-free mammary
epithelial growth medium (MEBM) (Lonza) supplemented
with 2 % of B27 (Invitrogen), 20 ng/mL hEGF (PEPROTECH),
20 ng/mL bFGF (Provitro), and 4 mg/mL heparin (Sigma),
10 ng/ml hydrocortisone (Sigma) and 5 mg/ml Insulin (Sigma)
and 1% Penicillin/Streptomycin (Lonza) while MCF-7 cells
were grown in a serum-free mammary epithelial growth
medium (MEBM) supplemented with B27 (Invitrogen), 20 ng/
mL hEGF (PEPROTECH) 5 mg/ml Insulin (Sigma) and 1%
Penicillin/ Streptomycin (Lonza). Primary mammospheres
after 10 d were collected by gentle centrifugation (800 rpm)
and dissociated enzymatically to be re-seeded to obtain
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secondary mammospheres. The number of mammospheres
( 250 mm) per well was then counted and percentages of
mammospheres forming efﬁciencies (% MFE) was calculated as
a number of mammospheres divided by the plated cell number
and multiplied for a hundred.
PKH26 assay
Primary mammospheres were collected and dissociated enzy-
matically, resuspendend in PBS and labeled with PKH26
(Sigma) 10¡7 M for 5 min. To stop the staining, an equal vol-
ume of serum was added to the cells and incubated for 1 min-
ute to allow binding of excess dye. Labeled cells were re-plated
(1000cells/well) in ultralow attachment plates in mammo-
spheres culture medium to obtain secondary mammospheres.
After 10 days, secondary mammospheres were analyzed by
confocal microscopy.
Drug treatments
Cells in 3D culture and primary mammospheres were treated
with 100nM thapsigargin. For cells in 3D culture, the drug was
added after a week and replaced every 3 days, while for primary
mammospheres, 100nM of thapsigargin was added 6h before
collection, dissociation, and re-seeding to obtain secondary
mammospheres.
Flow cytometric analysis and cell sorting
Single cell suspension of adherent cells or mammospheres was
stained with CD24-FITC (BD Biosciences) and CD44-PE (BD
Biosciences). Appropriate isotype controls were used to set the
threshold for CD44 and CD24 positive cells. Cells were incu-
bated with the appropriate antibodies at room temperature in
the dark for 30 minutes, then washed with PBS and ﬁnally
resuspended in 500mL of PBS. 10,000 cells were analyzed for
each condition using a FACSCalibur ﬂow cytometer (BD Bio-
sciences); data were analyzed using FlowJo software (Tree Star,
Ashland, USA).
To separate CD44high/CD24low MCF10AT cells, ﬂow cyto-
metric cell sorting was performed on single-cell suspensions
previously stained with CD44 and CD24 antibody.
Quantitative Real Time PCR (qRT-PCR) analysis of ES cells
ES cells were transiently transfected using Lipofectamine
RNAiMAX (Invitrogen) according to the manufacturer’s
instructions, using a control siRNA (AllStars Negative Control
siRNA, Qiagen) or a siRNA targeting mouse CAPNS1 (50 -
CAGGCTATATACAAACGCTTT - 30). 72 hours later, ES cells
were re-seeded and subjected to a second round of siRNA
silencing, and grown for 72 hours in mESC differentiation
medium: DMEM supplemented with 15% ES cell certiﬁed
serum (Invitrogen), 1% non-essential amino acids (Gibco),
1 mM sodium pyruvate (Gibco), 0.1 mM ß-mercaptoethanol
and 1% penicillin/streptomycin (Lonza).
For quantitative real-time PCR, total RNA from ES cells was
puriﬁed using QIAzol lysis reagent (Qiagen). 1.5 mg of total
RNA was treated with DNase (RQ1, Promega) and subjected to
reverse transcription in the presence of random primers
(Promega) or oligo dT primers using SuperScriptIII Reverse
Transcriptase (Invitrogen) according to the manufacturer’s
suggestions. Quantitative real-time PCR was performed on Ste-
pOnePlus real-time PCR machine (Applied Biosystems), using
SYBR Green Universal PCR Master Mix (Applied Biosystems)
and the following oligonucleotides targeting mouse genes:
CAPNS1 for TTCATCAGCTGCTTGGTCAG, rev AGC-
CACTCCTGGATGTTCAC; USP1 for CATTTGAAGTGC
TTTGCTGCT, rev CTTGGAAAGTCCACCACCAT; Gapdh:
for TTCACCACCATGGAGAAGGC, rev CCCTTTTGGC
TCCAC; Nanog for TTCTTGCTTACAAGGGTCTGC, rev
AGAGGAAGGGCGAGGAGA; Oct4 for CAGGGACACCT
TTCCCAGGG, rev TTTAAGAACAAAATGATGAG; Sox2 for
TGCTGCCTCTTTAAGACTAGGG, rev TCGGGCTCCAAAC
TTCTCT.
Quantitative RT (qRT-pCR) was performed in triplicate and
relative expression levels were normalized to controls by using
the comparative Ct (DDCt) method, using Gapdh mRNA as
internal control.
Western blot analysis
Western blotting was performed on cells protein lysates
(50 mM Tris-HCl pH 7.5; 150 mM NaCl, 5 mM EDTA, 1% Tri-
ton X-100, 0.5 mM NaF, 1 mM Sodium orthovanadate, com-
plete protease inhibitor cocktail Sigma-Aldrich). When
speciﬁed, nuclear and cytoplasmic extracts were prepared using
nuclear and cytoplasmic extraction reagents (ThermoScientiﬁc)
according to manufacturer instructions. Lysates were clariﬁed
by centrifugation for 15 min at 4C and protein concentrations
were assessed using Bradford protein assay (BioRad Laborato-
ries). Samples containing equal amounts of protein were boiled
in SDS sample buffer, resolved using SDS-PAGE (15-20 mg
protein per lane) and transferred to nitrocellulose membranes.
The blots were then probed with the following antibodies:
anti-b-catenin active (Abcam), anti-E-cadherin (Takara bio),
anti-Capns1, anti-Capn2, anti-sb-catenin, anti-a Actin (Sigma-
Aldrich), anti-Capn1, anti-p21, anti-p53, anti-b-catenin,
anti-Cdc27, anti-Cdc6 (Santa Cruz), anti-cdh1 (Calbiochem),
anti-USP1 (Bethyl Laboratories) and anti-vimentin (BD
Bioscences), overnight at 4C, then washed, incubated with
horseradish peroxidase-conjugated secondary antibodies
(Sigma), and analyzed by enhanced chemiluminescence
Statistical analysis
Results are expressed as means § standard deviations of at least
3 independent experiments. Statistical analysis was performed
using Student’s t test with the level of signiﬁcance set at
P < 0.05.
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